RECK and prostate cancer: Investigations on whether RECK is a target of miR-21 in the DU-145 prostate cancer cell line have revealed that miR-21 directly inhibits RECK and plays a significant role in the progression of prostate cancer by controlling RECK (Reis et al., 2012).